Huashan Liu

10PUBLICATIONS
47CO-AUTHORS
Tumour immunologyLiquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 20, 2026
SIRT1 Inhibits T Cell Infiltration and Tertiary Lymphoid Structure Formation to Promote Radioimmunotherapy Resistance.

|Mar 27, 2026
Lactylation at lysine 145 fosters KAT8-TIP60 complex formation to promote p53 acetylation at lysine 120 and its pro-apoptotic function.

Huashan Liu, Ze Li, Dongxu Lei

|Jan 21, 2026
Neoadjuvant chemoradiotherapy plus sintilimab in proficient mismatch repair locally advanced rectal cancer with intermediate/high-immunoscore (SILAR): a single-arm phase II trial.

Xiaobin Zheng, Huashan Liu, Lishuo Shi

|Feb 26, 2025
Clinical Association of Negative Lymph Nodes With Adjuvant Chemotherapy in Patients With T3N0 Rectal Cancer.

Dongxu Lei, Zhanzhen Liu, Xinyi Kang

|Jan 01, 2025
Glutamic-pyruvic transaminase 1 deficiency-mediated metabolic reprogramming facilitates colorectal adenoma-carcinoma progression.

Li Xiong, Xin Yang, Huashan Liu

|May 17, 2024
The relationship of KRAS expression with KRAS status, prognosis, and tumor-infiltrated T lymphocytes in colorectal cancer.

Yebohao Zhou, Ziwei Zeng, Ze Li

Pageof 2

Frequent Collaborators

8 joint publications

Liang Kang

6 joint publications

Ziwei Zeng

3 joint publications

Zhenxing Liang

3 joint publications

Wenxin Li